FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Cells2020; 9(6); 1453; doi: 10.3390/cells9061453

Veterinary Regenerative Medicine for Musculoskeletal Disorders: Can Mesenchymal Stem/Stromal Cells and Their Secretome Be the New Frontier?

Abstract: Regenerative medicine aims to restore the normal function of diseased or damaged cells, tissues, and organs using a set of different approaches, including cell-based therapies. In the veterinary field, regenerative medicine is strongly related to the use of mesenchymal stromal cells (MSCs), which belong to the body repair system and are defined as multipotent progenitor cells, able to self-replicate and to differentiate into different cell types. This review aims to take stock of what is known about the MSCs and their use in the veterinary medicine focusing on clinical reports on dogs and horses in musculoskeletal diseases, a research field extensively reported in the literature data. Finally, a perspective regarding the use of the secretome and/or extracellular vesicles (EVs) in the veterinary field to replace parental MSCs is provided. The pharmaceuticalization of EVs is wished due to the realization of a Good Manufacturing Practice (GMP product suitable for clinical trials.
Get Full Text
Publication Date: 2020-06-11 PubMed ID: 32545382PubMed Central: PMC7349187DOI: 10.3390/cells9061453Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article is about exploring the use of mesenchymal stromal cells (MSCs) and their secretome as part of regenerative medicine in veterinary care, particularly in treating musculoskeletal diseases in dogs and horses. It also discusses the potential of using extracellular vesicles (EVs) in the field.

Overview and Aim

The article begins with an overview of regenerative medicine, emphasizing that its primary goal is to restore the function of damaged or diseased cells, tissues, and organs using varying approaches, including cell-based therapies. It then explains that in the field of veterinary medicine, the focus of regenerative medicine primarily falls on mesenchymal stromal cells (MSCs), a type of cell that plays a critical role in the body’s natural repair mechanism.

The purpose of the review article is to evaluate current knowledge on the use of MSCs in veterinary medicine, with an emphasis on their application in treating musculoskeletal diseases in dogs and horses. These cases were chosen due to the extensive literature data available on them.

Mesenchymal Stromal Cells (MSCs)

  • The article describes MSCs as multipotent progenitor cells. This means they have the ability to self-replicate and differentiate into various cell types, lending them a significant role in natural repair processes.
  • These cells are believed to be particularly beneficial in veterinary medicine, and there is considerable research investigating their application.

Use of MSCs in Veterinary Medicine

  • The paper highlights the application of MSCs in treating musculoskeletal diseases in dogs and horses. This is an extensively researched area, making it an ideal focus for the review.

The Secretome and Extracellular Vesicles (EVs)

  • Apart from MSCs, the review foresees the potential use of the secretome and/or extracellular vesicles (EVs) in regenerative medicine. The secretome refers to the release of substances by cells, which can include EVs—tiny structures that can carry proteins, lipids, and nucleic acids between cells.
  • These entities hold appealing prospects to the point that a shift from the use of parental MSCs to using EVs as therapeutic tools is suggested in the review. This shift could lead to improved, more effective therapies.
  • The authors express their wishes for the pharmaceuticalization of EVs, indicating a need for standardizing guidelines and creating Good Manufacturing Practice (GMP)-compliant products for clinical trials. This denotes the importance of ensuring the safety, efficacy, and quality of potential EV-based therapies.

Cite This Article

APA
Mocchi M, Dotti S, Bue MD, Villa R, Bari E, Perteghella S, Torre ML, Grolli S. (2020). Veterinary Regenerative Medicine for Musculoskeletal Disorders: Can Mesenchymal Stem/Stromal Cells and Their Secretome Be the New Frontier? Cells, 9(6), 1453. https://doi.org/10.3390/cells9061453

Publication

Cells
ISSN: 2073-4409
NlmUniqueID: 101600052
Country: Switzerland
Language: English
Volume: 9
Issue: 6
PII: 1453

Researcher Affiliations

Mocchi, Michela
  • Department of Drug Sciences, University of Pavia, 27100 Pavia, Italy.
Dotti, Silvia
  • Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, 25124 Brescia, Italy.
Bue, Maurizio Del
  • Freelance Veterinary Medical Doctor, 43121 Parma, Italy.
Villa, Riccardo
  • Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, 25124 Brescia, Italy.
Bari, Elia
  • Department of Drug Sciences, University of Pavia, 27100 Pavia, Italy.
Perteghella, Sara
  • Department of Drug Sciences, University of Pavia, 27100 Pavia, Italy.
  • PharmaExceed S.r.l., 27100 Pavia, Italy.
Torre, Maria Luisa
  • Department of Drug Sciences, University of Pavia, 27100 Pavia, Italy.
  • PharmaExceed S.r.l., 27100 Pavia, Italy.
Grolli, Stefano
  • Department of Veterinary Medical Science, University of Parma, 43121 Parma, Italy.

MeSH Terms

  • Animals
  • Cryopreservation
  • Disease Models, Animal
  • Mesenchymal Stem Cells / cytology
  • Musculoskeletal Diseases / therapy
  • Musculoskeletal Diseases / veterinary
  • Regenerative Medicine
  • Veterinary Medicine

Conflict of Interest Statement

M.L.T., and S.P. are co-founders and members of the advisory board of PharmaExceed S.r.l.

References

This article includes 123 references
  1. de Girolamo L, Lucarelli E, Alessandri G, Avanzini MA, Bernardo ME, Biagi E, Brini AT, D'Amico G, Fagioli F, Ferrero I, Locatelli F, Maccario R, Marazzi M, Parolini O, Pessina A, Torre ML, Italian Mesenchymal Stem Cell Group. Mesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapy.. Curr Pharm Des 2013;19(13):2459-73.
    doi: 10.2174/1381612811319130015pmc: PMC3788322pubmed: 23278600google scholar: lookup
  2. Bari E, Perteghella S, Di Silvestre D, Sorlini M, Catenacci L, Sorrenti M, Marrubini G, Rossi R, Tripodo G, Mauri P, Marazzi M, Torre ML. Pilot Production of Mesenchymal Stem/Stromal Freeze-Dried Secretome for Cell-Free Regenerative Nanomedicine: A Validated GMP-Compliant Process.. Cells 2018 Oct 30;7(11).
    doi: 10.3390/cells7110190pmc: PMC6262564pubmed: 30380806google scholar: lookup
  3. Robey P. "Mesenchymal stem cells": fact or fiction, and implications in their therapeutic use.. F1000Res 2017;6.
    doi: 10.12688/f1000research.10955.1pmc: PMC5399967pubmed: 28491279google scholar: lookup
  4. Katsuda T, Kosaka N, Takeshita F, Ochiya T. The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles.. Proteomics 2013 May;13(10-11):1637-53.
    doi: 10.1002/pmic.201200373pubmed: 23335344google scholar: lookup
  5. Kidd S, Spaeth E, Dembinski JL, Dietrich M, Watson K, Klopp A, Battula VL, Weil M, Andreeff M, Marini FC. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging.. Stem Cells 2009 Oct;27(10):2614-23.
    doi: 10.1002/stem.187pmc: PMC4160730pubmed: 19650040google scholar: lookup
  6. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues.. J Cell Sci 2006 Jun 1;119(Pt 11):2204-13.
    doi: 10.1242/jcs.02932pubmed: 16684817google scholar: lookup
  7. Tessier L, Bienzle D, Williams LB, Koch TG. Phenotypic and immunomodulatory properties of equine cord blood-derived mesenchymal stromal cells.. PLoS One 2015;10(4):e0122954.
    doi: 10.1371/journal.pone.0122954pmc: PMC4406608pubmed: 25902064google scholar: lookup
  8. Duan W, Lopez MJ, Hicok K. Adult multipotent stromal cell cryopreservation: Pluses and pitfalls.. Vet Surg 2018 Jan;47(1):19-29.
    doi: 10.1111/vsu.12730pmc: PMC5813167pubmed: 29023790google scholar: lookup
  9. Barrachina L, Romero A, Zaragoza P, Rodellar C, Vázquez FJ. Practical considerations for clinical use of mesenchymal stem cells: From the laboratory to the horse.. Vet J 2018 Aug;238:49-57.
    doi: 10.1016/j.tvjl.2018.07.004pubmed: 30103915google scholar: lookup
  10. Orbay H, Tobita M, Mizuno H. Mesenchymal stem cells isolated from adipose and other tissues: basic biological properties and clinical applications.. Stem Cells Int 2012;2012:461718.
    doi: 10.1155/2012/461718pmc: PMC3361347pubmed: 22666271google scholar: lookup
  11. Sacchetti B, Funari A, Remoli C, Giannicola G, Kogler G, Liedtke S, Cossu G, Serafini M, Sampaolesi M, Tagliafico E, Tenedini E, Saggio I, Robey PG, Riminucci M, Bianco P. No Identical "Mesenchymal Stem Cells" at Different Times and Sites: Human Committed Progenitors of Distinct Origin and Differentiation Potential Are Incorporated as Adventitial Cells in Microvessels.. Stem Cell Reports 2016 Jun 14;6(6):897-913.
    doi: 10.1016/j.stemcr.2016.05.011pmc: PMC4912436pubmed: 27304917google scholar: lookup
  12. Iacono E, Merlo B, Romagnoli N, Rossi B, Ricci F, Spadari A. Equine Bone Marrow and Adipose Tissue Mesenchymal Stem Cells: Cytofluorimetric Characterization, In Vitro Differentiation, and Clinical Application. J. Equine Vet. Sci. 2015;35:130–140.
    doi: 10.1016/j.jevs.2014.12.010google scholar: lookup
  13. Bearden RN, Huggins SS, Cummings KJ, Smith R, Gregory CA, Saunders WB. In-vitro characterization of canine multipotent stromal cells isolated from synovium, bone marrow, and adipose tissue: a donor-matched comparative study.. Stem Cell Res Ther 2017 Oct 3;8(1):218.
    doi: 10.1186/s13287-017-0639-6pmc: PMC5627404pubmed: 28974260google scholar: lookup
  14. Toupadakis CA, Wong A, Genetos DC, Cheung WK, Borjesson DL, Ferraro GL, Galuppo LD, Leach JK, Owens SD, Yellowley CE. Comparison of the osteogenic potential of equine mesenchymal stem cells from bone marrow, adipose tissue, umbilical cord blood, and umbilical cord tissue.. Am J Vet Res 2010 Oct;71(10):1237-45.
    doi: 10.2460/ajvr.71.10.1237pubmed: 20919913google scholar: lookup
  15. Vidal MA, Kilroy GE, Lopez MJ, Johnson JR, Moore RM, Gimble JM. Characterization of equine adipose tissue-derived stromal cells: adipogenic and osteogenic capacity and comparison with bone marrow-derived mesenchymal stromal cells.. Vet Surg 2007 Oct;36(7):613-22.
    doi: 10.1111/j.1532-950X.2007.00313.xpubmed: 17894587google scholar: lookup
  16. Giovannini S, Brehm W, Mainil-Varlet P, Nesic D. Multilineage differentiation potential of equine blood-derived fibroblast-like cells.. Differentiation 2008 Feb;76(2):118-29.
    doi: 10.1111/j.1432-0436.2007.00207.xpubmed: 17697129google scholar: lookup
  17. Del Bue M, Riccò S, Ramoni R, Conti V, Gnudi G, Grolli S. Equine adipose-tissue derived mesenchymal stem cells and platelet concentrates: their association in vitro and in vivo.. Vet Res Commun 2008 Sep;32 Suppl 1:S51-5.
    doi: 10.1007/s11259-008-9093-3pubmed: 18683070google scholar: lookup
  18. Martinello T, Bronzini I, Maccatrozzo L, Mollo A, Sampaolesi M, Mascarello F, Decaminada M, Patruno M. Canine adipose-derived-mesenchymal stem cells do not lose stem features after a long-term cryopreservation.. Res Vet Sci 2011 Aug;91(1):18-24.
    doi: 10.1016/j.rvsc.2010.07.024pubmed: 20732703google scholar: lookup
  19. Jezierska-Woźniak K, Nosarzewska D, Tutas A, Mikołajczyk A, Okliński M, Jurkowski MK. [Use of adipose tissue as a source of mesenchymal stem cells].. Postepy Hig Med Dosw (Online) 2010 Jul 27;64:326-32.
    pubmed: 20679688
  20. Nava S, Sordi V, Pascucci L, Tremolada C, Ciusani E, Zeira O, Cadei M, Soldati G, Pessina A, Parati E, Slevin M, Alessandri G. Long-Lasting Anti-Inflammatory Activity of Human Microfragmented Adipose Tissue.. Stem Cells Int 2019;2019:5901479.
    doi: 10.1155/2019/5901479pmc: PMC6399530pubmed: 30915125google scholar: lookup
  21. You D, Jang MJ, Kim BH, Song G, Lee C, Suh N, Jeong IG, Ahn TY, Kim CS. Comparative study of autologous stromal vascular fraction and adipose-derived stem cells for erectile function recovery in a rat model of cavernous nerve injury.. Stem Cells Transl Med 2015 Apr;4(4):351-8.
    doi: 10.5966/sctm.2014-0161pmc: PMC4367505pubmed: 25792486google scholar: lookup
  22. Kemilew J, Sobczyńska-Rak A, Żylińska B, Szponder T, Nowicka B, Urban B. The Use of Allogenic Stromal Vascular Fraction (SVF) Cells in Degenerative Joint Disease of the Spine in Dogs.. In Vivo 2019 Jul-Aug;33(4):1109-1117.
    doi: 10.21873/invivo.11580pmc: PMC6689365pubmed: 31280199google scholar: lookup
  23. Minteer D, Marra KG, Rubin JP. Adipose-derived mesenchymal stem cells: biology and potential applications.. Adv Biochem Eng Biotechnol 2013;129:59-71.
    doi: 10.1007/10_2012_146pubmed: 22825719google scholar: lookup
  24. Kuznetsov SA, Mankani MH, Gronthos S, Satomura K, Bianco P, Robey PG. Circulating skeletal stem cells.. J Cell Biol 2001 May 28;153(5):1133-40.
    doi: 10.1083/jcb.153.5.1133pmc: PMC2174322pubmed: 11381097google scholar: lookup
  25. Roufosse CA, Direkze NC, Otto WR, Wright NA. Circulating mesenchymal stem cells.. Int J Biochem Cell Biol 2004 Apr;36(4):585-97.
    doi: 10.1016/j.biocel.2003.10.007pubmed: 15010325google scholar: lookup
  26. Koerner J, Nesic D, Romero JD, Brehm W, Mainil-Varlet P, Grogan SP. Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells.. Stem Cells 2006 Jun;24(6):1613-9.
    doi: 10.1634/stemcells.2005-0264pubmed: 16769763google scholar: lookup
  27. Santos VH, Pfeifer JPH, de Souza JB, Milani BHG, de Oliveira RA, Assis MG, Deffune E, Moroz A, Alves ALG. Culture of mesenchymal stem cells derived from equine synovial membrane in alginate hydrogel microcapsules.. BMC Vet Res 2018 Mar 27;14(1):114.
    doi: 10.1186/s12917-018-1425-0pmc: PMC5870504pubmed: 29587733google scholar: lookup
  28. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.. Stem Cells 2006 May;24(5):1294-301.
    doi: 10.1634/stemcells.2005-0342pubmed: 16410387google scholar: lookup
  29. Schuh EM, Friedman MS, Carrade DD, Li J, Heeke D, Oyserman SM, Galuppo LD, Lara DJ, Walker NJ, Ferraro GL, Owens SD, Borjesson DL. Identification of variables that optimize isolation and culture of multipotent mesenchymal stem cells from equine umbilical-cord blood.. Am J Vet Res 2009 Dec;70(12):1526-35.
    doi: 10.2460/ajvr.70.12.1526pubmed: 19951125google scholar: lookup
  30. Iacono E, Lanci A, Merlo B, Ricci F, Pirrone A, Antonelli C, Mariella J, Castagnetti C. Effects of amniotic fluid mesenchymal stem cells in carboxymethyl cellulose gel on healing of spontaneous pressure sores: Clinical outcome in seven hospitalized neonatal foals. Turk. J. Biol. 2016;40:484–492.
    doi: 10.3906/biy-1507-147google scholar: lookup
  31. Iacono E, Brunori L, Pirrone A, Pagliaro PP, Ricci F, Tazzari PL, Merlo B. Isolation, characterization and differentiation of mesenchymal stem cells from amniotic fluid, umbilical cord blood and Wharton's jelly in the horse.. Reproduction 2012 Apr;143(4):455-68.
    doi: 10.1530/REP-10-0408pubmed: 22274885google scholar: lookup
  32. Passeri S, Nocchi F, Lamanna R, Lapi S, Miragliotta V, Giannessi E, Abramo F, Stornelli MR, Matarazzo M, Plenteda D, Urciuoli P, Scatena F, Coli A. Isolation and expansion of equine umbilical cord-derived matrix cells (EUCMCs).. Cell Biol Int 2009 Jan;33(1):100-5.
    doi: 10.1016/j.cellbi.2008.10.012pubmed: 18996215google scholar: lookup
  33. Ranera B, Lyahyai J, Romero A, Vázquez FJ, Remacha AR, Bernal ML, Zaragoza P, Rodellar C, Martín-Burriel I. Immunophenotype and gene expression profiles of cell surface markers of mesenchymal stem cells derived from equine bone marrow and adipose tissue.. Vet Immunol Immunopathol 2011 Nov 15;144(1-2):147-54.
    doi: 10.1016/j.vetimm.2011.06.033pubmed: 21782255google scholar: lookup
  34. Vidal MA, Walker NJ, Napoli E, Borjesson DL. Evaluation of senescence in mesenchymal stem cells isolated from equine bone marrow, adipose tissue, and umbilical cord tissue.. Stem Cells Dev 2012 Jan 20;21(2):273-83.
    doi: 10.1089/scd.2010.0589pubmed: 21410356google scholar: lookup
  35. Naskou MC, Sumner SM, Chocallo A, Kemelmakher H, Thoresen M, Copland I, Galipeau J, Peroni JF. Platelet lysate as a novel serum-free media supplement for the culture of equine bone marrow-derived mesenchymal stem cells.. Stem Cell Res Ther 2018 Mar 22;9(1):75.
    doi: 10.1186/s13287-018-0823-3pmc: PMC5863827pubmed: 29566772google scholar: lookup
  36. Russell KA, Koch TG. Equine platelet lysate as an alternative to fetal bovine serum in equine mesenchymal stromal cell culture - too much of a good thing?. Equine Vet J 2016 Mar;48(2):261-4.
    doi: 10.1111/evj.12440pubmed: 25772755google scholar: lookup
  37. Bari E, Perteghella S, Faragò S, Torre ML. Association of silk sericin and platelet lysate: Premises for the formulation of wound healing active medications.. Int J Biol Macromol 2018 Nov;119:37-47.
    doi: 10.1016/j.ijbiomac.2018.07.142pubmed: 30048722google scholar: lookup
  38. Verdanova M, Pytlik R, Kalbacova MH. Evaluation of sericin as a fetal bovine serum-replacing cryoprotectant during freezing of human mesenchymal stromal cells and human osteoblast-like cells.. Biopreserv Biobank 2014 Apr;12(2):99-105.
    doi: 10.1089/bio.2013.0078pmc: PMC3995509pubmed: 24749876google scholar: lookup
  39. Espina M, Jülke H, Brehm W, Ribitsch I, Winter K, Delling U. Evaluation of transport conditions for autologous bone marrow-derived mesenchymal stromal cells for therapeutic application in horses.. PeerJ 2016;4:e1773.
    doi: 10.7717/peerj.1773pmc: PMC4806605pubmed: 27019778google scholar: lookup
  40. Garvican ER, Cree S, Bull L, Smith RK, Dudhia J. Erratum to: Viability of equine mesenchymal stem cells during transport and implantation.. Stem Cell Res Ther 2016 Nov 9;7(1):161.
    doi: 10.1186/s13287-016-0423-zpmc: PMC5103379pubmed: 27829446google scholar: lookup
  41. Broeckx S, Suls M, Beerts C, Vandenberghe A, Seys B, Wuertz-Kozak K, Duchateau L, Spaas JH. Allogenic mesenchymal stem cells as a treatment for equine degenerative joint disease: a pilot study.. Curr Stem Cell Res Ther 2014;9(6):497-503.
    doi: 10.2174/1574888X09666140826110601pubmed: 25175766google scholar: lookup
  42. Mercati F, Pascucci L, Curina G, Scocco P, Tardella FM, Dall'aglio C, Marini C, Ceccarelli P. Evaluation of storage conditions on equine adipose tissue-derived multipotent mesenchymal stromal cells.. Vet J 2014 May;200(2):339-42.
    doi: 10.1016/j.tvjl.2014.02.018pubmed: 24656629google scholar: lookup
  43. Bronzini I, Patruno M, Iacopetti I, Martinello T. Influence of temperature, time and different media on mesenchymal stromal cells shipped for clinical application.. Vet J 2012 Oct;194(1):121-3.
    doi: 10.1016/j.tvjl.2012.03.010pubmed: 22503718google scholar: lookup
  44. Zhang N, Dietrich MA, Lopez MJ. Therapeutic doses of multipotent stromal cells from minimal adipose tissue.. Stem Cell Rev Rep 2014 Aug;10(4):600-11.
    doi: 10.1007/s12015-014-9508-1pmc: PMC4127443pubmed: 24850472google scholar: lookup
  45. Martinello T, Bronzini I, Maccatrozzo L, Iacopetti I, Sampaolesi M, Mascarello F, Patruno M. Cryopreservation does not affect the stem characteristics of multipotent cells isolated from equine peripheral blood.. Tissue Eng Part C Methods 2010 Aug;16(4):771-81.
    doi: 10.1089/ten.tec.2009.0512pubmed: 19839741google scholar: lookup
  46. Torre ML, Lucarelli E, Guidi S, Ferrari M, Alessandri G, De Girolamo L, Pessina A, Ferrero I. Ex vivo expanded mesenchymal stromal cell minimal quality requirements for clinical application.. Stem Cells Dev 2015 Mar 15;24(6):677-85.
    doi: 10.1089/scd.2014.0299pubmed: 25517941google scholar: lookup
  47. Williams LB, Russell KA, Koenig JB, Koch TG. Aspiration, but not injection, decreases cultured equine mesenchymal stromal cell viability.. BMC Vet Res 2016 Mar 7;12:45.
    doi: 10.1186/s12917-016-0671-2pmc: PMC4780131pubmed: 26952099google scholar: lookup
  48. Schnabel LV, Fortier LA, McIlwraith CW, Nobert KM. Therapeutic use of stem cells in horses: which type, how, and when?. Vet J 2013 Sep;197(3):570-7.
    doi: 10.1016/j.tvjl.2013.04.018pubmed: 23778257google scholar: lookup
  49. Sole A, Spriet M, Galuppo LD, Padgett KA, Borjesson DL, Wisner ER, Brosnan RJ, Vidal MA. Scintigraphic evaluation of intra-arterial and intravenous regional limb perfusion of allogeneic bone marrow-derived mesenchymal stem cells in the normal equine distal limb using (99m) Tc-HMPAO.. Equine Vet J 2012 Sep;44(5):594-9.
    doi: 10.1111/j.2042-3306.2011.00530.xpubmed: 22212017google scholar: lookup
  50. Siegel G, Kluba T, Hermanutz-Klein U, Bieback K, Northoff H, Schäfer R. Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells.. BMC Med 2013 Jun 11;11:146.
    doi: 10.1186/1741-7015-11-146pmc: PMC3694028pubmed: 23758701google scholar: lookup
  51. Carrade DD, Owens SD, Galuppo LD, Vidal MA, Ferraro GL, Librach F, Buerchler S, Friedman MS, Walker NJ, Borjesson DL. Clinicopathologic findings following intra-articular injection of autologous and allogeneic placentally derived equine mesenchymal stem cells in horses.. Cytotherapy 2011 Apr;13(4):419-30.
    doi: 10.3109/14653249.2010.536213pubmed: 21105841google scholar: lookup
  52. Shah K, Drury T, Roic I, Hansen P, Malin M, Boyd R, Sumer H, Ferguson R. Outcome of Allogeneic Adult Stem Cell Therapy in Dogs Suffering from Osteoarthritis and Other Joint Defects.. Stem Cells Int 2018;2018:7309201.
    doi: 10.1155/2018/7309201pmc: PMC6046133pubmed: 30050578google scholar: lookup
  53. Guest DJ, Smith MR, Allen WR. Monitoring the fate of autologous and allogeneic mesenchymal progenitor cells injected into the superficial digital flexor tendon of horses: preliminary study.. Equine Vet J 2008 Mar;40(2):178-81.
    doi: 10.2746/042516408X276942pubmed: 18267891google scholar: lookup
  54. Brandão JS, Alvarenga ML, Pfeifer JPH, Dos Santos VH, Fonseca-Alves CE, Rodrigues M, Laufer-Amorim R, Castillo JAL, Alves ALG. Allogeneic mesenchymal stem cell transplantation in healthy equine superficial digital flexor tendon: A study of the local inflammatory response.. Res Vet Sci 2018 Jun;118:423-430.
    doi: 10.1016/j.rvsc.2018.03.012pubmed: 29715649google scholar: lookup
  55. Brehm W, Burk J, Delling U, Gittel C, Ribitsch I. Stem cell-based tissue engineering in veterinary orthopaedics.. Cell Tissue Res 2012 Mar;347(3):677-688.
    doi: 10.1007/s00441-011-1316-1pubmed: 22287044google scholar: lookup
  56. Gala K, Burdzińska A, Idziak M, Wilczek E, Pączek L. Transplantation of mesenchymal stem cells into the skeletal muscle induces cytokine generation.. Cytokine 2013 Oct;64(1):243-50.
    doi: 10.1016/j.cyto.2013.06.314pubmed: 23859809google scholar: lookup
  57. Zayed M, Adair S, Ursini T, Schumacher J, Misk N, Dhar M. Concepts and challenges in the use of mesenchymal stem cells as a treatment for cartilage damage in the horse.. Res Vet Sci 2018 Jun;118:317-323.
    doi: 10.1016/j.rvsc.2018.03.011pubmed: 29601969google scholar: lookup
  58. Litzke LE, Wagner E, Baumgaertner W, Hetzel U, Josimović-Alasević O, Libera J. Repair of extensive articular cartilage defects in horses by autologous chondrocyte transplantation.. Ann Biomed Eng 2004 Jan;32(1):57-69.
    doi: 10.1023/B:ABME.0000007791.81433.1apubmed: 14964722google scholar: lookup
  59. Sasaki A, Mizuno M, Ozeki N, Katano H, Otabe K, Tsuji K, Koga H, Mochizuki M, Sekiya I. Canine mesenchymal stem cells from synovium have a higher chondrogenic potential than those from infrapatellar fat pad, adipose tissue, and bone marrow.. PLoS One 2018;13(8):e0202922.
    doi: 10.1371/journal.pone.0202922pmc: PMC6107231pubmed: 30138399google scholar: lookup
  60. Lim JK, Hui J, Li L, Thambyah A, Goh J, Lee EH. Enhancement of tendon graft osteointegration using mesenchymal stem cells in a rabbit model of anterior cruciate ligament reconstruction.. Arthroscopy 2004 Nov;20(9):899-910.
    doi: 10.1016/S0749-8063(04)00653-Xpubmed: 15525922google scholar: lookup
  61. Zeira O, Scaccia S, Pettinari L, Ghezzi E, Asiag N, Martinelli L, Zahirpour D, Dumas MP, Konar M, Lupi DM, Fiette L, Pascucci L, Leonardi L, Cliff A, Alessandri G, Pessina A, Spaziante D, Aralla M. Intra-Articular Administration of Autologous Micro-Fragmented Adipose Tissue in Dogs with Spontaneous Osteoarthritis: Safety, Feasibility, and Clinical Outcomes.. Stem Cells Transl Med 2018 Nov;7(11):819-828.
    doi: 10.1002/sctm.18-0020pmc: PMC6216453pubmed: 30035380google scholar: lookup
  62. Guercio A, Di Marco P, Casella S, Cannella V, Russotto L, Purpari G, Di Bella S, Piccione G. Production of canine mesenchymal stem cells from adipose tissue and their application in dogs with chronic osteoarthritis of the humeroradial joints.. Cell Biol Int 2012 Feb;36(2):189-94.
    doi: 10.1042/CBI20110304pubmed: 21936851google scholar: lookup
  63. Hoffman AM, Dow SW. Concise Review: Stem Cell Trials Using Companion Animal Disease Models.. Stem Cells 2016 Jul;34(7):1709-29.
    doi: 10.1002/stem.2377pubmed: 27066769google scholar: lookup
  64. Vilar JM, Morales M, Santana A, Spinella G, Rubio M, Cuervo B, Cugat R, Carrillo JM. Controlled, blinded force platform analysis of the effect of intraarticular injection of autologous adipose-derived mesenchymal stem cells associated to PRGF-Endoret in osteoarthritic dogs.. BMC Vet Res 2013 Jul 2;9:131.
    doi: 10.1186/1746-6148-9-131pmc: PMC3716942pubmed: 23819757google scholar: lookup
  65. Vilar JM, Batista M, Morales M, Santana A, Cuervo B, Rubio M, Cugat R, Sopena J, Carrillo JM. Assessment of the effect of intraarticular injection of autologous adipose-derived mesenchymal stem cells in osteoarthritic dogs using a double blinded force platform analysis.. BMC Vet Res 2014 Jul 1;10:143.
    doi: 10.1186/1746-6148-10-143pmc: PMC4085658pubmed: 24984756google scholar: lookup
  66. Amable PR, Carias RB, Teixeira MV, da Cruz Pacheco I, Corrêa do Amaral RJ, Granjeiro JM, Borojevic R. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors.. Stem Cell Res Ther 2013 Jun 7;4(3):67.
    doi: 10.1186/scrt218pmc: PMC3706762pubmed: 23759113google scholar: lookup
  67. Cuervo B, Rubio M, Sopena J, Dominguez JM, Vilar J, Morales M, Cugat R, Carrillo JM. Hip osteoarthritis in dogs: a randomized study using mesenchymal stem cells from adipose tissue and plasma rich in growth factors.. Int J Mol Sci 2014 Jul 31;15(8):13437-60.
    doi: 10.3390/ijms150813437pmc: PMC4159804pubmed: 25089877google scholar: lookup
  68. Black LL, Gaynor J, Gahring D, Adams C, Aron D, Harman S, Gingerich DA, Harman R. Effect of adipose-derived mesenchymal stem and regenerative cells on lameness in dogs with chronic osteoarthritis of the coxofemoral joints: a randomized, double-blinded, multicenter, controlled trial.. Vet Ther 2007 Winter;8(4):272-84.
    pubmed: 18183546
  69. Black LL, Gaynor J, Adams C, Dhupa S, Sams AE, Taylor R, Harman S, Gingerich DA, Harman R. Effect of intraarticular injection of autologous adipose-derived mesenchymal stem and regenerative cells on clinical signs of chronic osteoarthritis of the elbow joint in dogs.. Vet Ther 2008 Fall;9(3):192-200.
    pubmed: 19003780
  70. Bogers SH. Cell-Based Therapies for Joint Disease in Veterinary Medicine: What We Have Learned and What We Need to Know.. Front Vet Sci 2018;5:70.
    doi: 10.3389/fvets.2018.00070pmc: PMC5911772pubmed: 29713634google scholar: lookup
  71. McIlwraith CW, Frisbie DD, Rodkey WG, Kisiday JD, Werpy NM, Kawcak CE, Steadman JR. Evaluation of intra-articular mesenchymal stem cells to augment healing of microfractured chondral defects.. Arthroscopy 2011 Nov;27(11):1552-61.
    doi: 10.1016/j.arthro.2011.06.002pubmed: 21862278google scholar: lookup
  72. Ferris DJ, Frisbie DD, Kisiday JD, McIlwraith CW, Hague BA, Major MD, Schneider RK, Zubrod CJ, Kawcak CE, Goodrich LR. Clinical outcome after intra-articular administration of bone marrow derived mesenchymal stem cells in 33 horses with stifle injury.. Vet Surg 2014 Mar;43(3):255-65.
    doi: 10.1111/j.1532-950X.2014.12100.xpubmed: 24433318google scholar: lookup
  73. Wang Y, Chen X, Cao W, Shi Y. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications.. Nat Immunol 2014 Nov;15(11):1009-16.
    doi: 10.1038/ni.3002pubmed: 25329189google scholar: lookup
  74. Nicpoń J, Marycz K, Grzesiak J. Therapeutic effect of adipose-derived mesenchymal stem cell injection in horses suffering from bone spavin.. Pol J Vet Sci 2013;16(4):753-4.
    doi: 10.2478/pjvs-2013-0107pubmed: 24597313google scholar: lookup
  75. Broeckx SY, Seys B, Suls M, Vandenberghe A, Mariën T, Adriaensen E, Declercq J, Van Hecke L, Braun G, Hellmann K, Spaas JH. Equine Allogeneic Chondrogenic Induced Mesenchymal Stem Cells Are an Effective Treatment for Degenerative Joint Disease in Horses.. Stem Cells Dev 2019 Mar 15;28(6):410-422.
    doi: 10.1089/scd.2018.0061pmc: PMC6441287pubmed: 30623737google scholar: lookup
  76. Smith R, McIlwraith W, Schweitzer R, Kadler K, Cook J, Caterson B, Dakin S, Heinegård D, Screen H, Stover S, Crevier-Denoix N, Clegg P, Collins M, Little C, Frisbie D, Kjaer M, van Weeren R, Werpy N, Denoix JM, Carr A, Goldberg A, Bramlage L, Smith M, Nixon A. Advances in the understanding of tendinopathies: a report on the Second Havemeyer Workshop on equine tendon disease.. Equine Vet J 2014 Jan;46(1):4-9.
    doi: 10.1111/evj.12128pubmed: 24329581google scholar: lookup
  77. Dowling BA, Dart AJ, Hodgson DR, Smith RK. Superficial digital flexor tendonitis in the horse.. Equine Vet J 2000 Sep;32(5):369-78.
    doi: 10.2746/042516400777591138pubmed: 11037257google scholar: lookup
  78. Chong AK, Chang J, Go JC. Mesenchymal stem cells and tendon healing.. Front Biosci (Landmark Ed) 2009 Jan 1;14(12):4598-605.
    doi: 10.2741/3552pubmed: 19273374google scholar: lookup
  79. Richardson LE, Dudhia J, Clegg PD, Smith R. Stem cells in veterinary medicine--attempts at regenerating equine tendon after injury.. Trends Biotechnol 2007 Sep;25(9):409-16.
    doi: 10.1016/j.tibtech.2007.07.009pubmed: 17692415google scholar: lookup
  80. Carvalho Ade M, Badial PR, Álvarez LE, Yamada AL, Borges AS, Deffune E, Hussni CA, Garcia Alves AL. Equine tendonitis therapy using mesenchymal stem cells and platelet concentrates: a randomized controlled trial.. Stem Cell Res Ther 2013 Jul 22;4(4):85.
    doi: 10.1186/scrt236pmc: PMC3854756pubmed: 23876512google scholar: lookup
  81. Smith RK, Werling NJ, Dakin SG, Alam R, Goodship AE, Dudhia J. Beneficial effects of autologous bone marrow-derived mesenchymal stem cells in naturally occurring tendinopathy.. PLoS One 2013;8(9):e75697.
    doi: 10.1371/annotation/a30a4b87-8904-4510-b0a8-5b6ca6097f9apmc: PMC3783421pubmed: 24086616google scholar: lookup
  82. Smith RK, Korda M, Blunn GW, Goodship AE. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment.. Equine Vet J 2003 Jan;35(1):99-102.
    doi: 10.2746/042516403775467388pubmed: 12553472google scholar: lookup
  83. Alves AG, Stewart AA, Dudhia J, Kasashima Y, Goodship AE, Smith RK. Cell-based therapies for tendon and ligament injuries.. Vet Clin North Am Equine Pract 2011 Aug;27(2):315-33.
    doi: 10.1016/j.cveq.2011.06.001pubmed: 21872761google scholar: lookup
  84. Godwin EE, Young NJ, Dudhia J, Beamish IC, Smith RK. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon.. Equine Vet J 2012 Jan;44(1):25-32.
    doi: 10.1111/j.2042-3306.2011.00363.xpubmed: 21615465google scholar: lookup
  85. Kol A, Wood JA, Carrade Holt DD, Gillette JA, Bohannon-Worsley LK, Puchalski SM, Walker NJ, Clark KC, Watson JL, Borjesson DL. Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses.. Stem Cell Res Ther 2015 Apr 15;6(1):73.
    doi: 10.1186/s13287-015-0050-0pmc: PMC4446064pubmed: 25888916google scholar: lookup
  86. Barberini DJ, Aleman M, Aristizabal F, Spriet M, Clark KC, Walker NJ, Galuppo LD, Amorim RM, Woolard KD, Borjesson DL. Safety and tracking of intrathecal allogeneic mesenchymal stem cell transplantation in healthy and diseased horses.. Stem Cell Res Ther 2018 Apr 10;9(1):96.
    doi: 10.1186/s13287-018-0849-6pmc: PMC5891950pubmed: 29631634google scholar: lookup
  87. Beerts C, Suls M, Broeckx SY, Seys B, Vandenberghe A, Declercq J, Duchateau L, Vidal MA, Spaas JH. Tenogenically Induced Allogeneic Peripheral Blood Mesenchymal Stem Cells in Allogeneic Platelet-Rich Plasma: 2-Year Follow-up after Tendon or Ligament Treatment in Horses.. Front Vet Sci 2017;4:158.
    doi: 10.3389/fvets.2017.00158pmc: PMC5622984pubmed: 29018808google scholar: lookup
  88. Romero A, Barrachina L, Ranera B, Remacha AR, Moreno B, de Blas I, Sanz A, Vázquez FJ, Vitoria A, Junquera C, Zaragoza P, Rodellar C. Comparison of autologous bone marrow and adipose tissue derived mesenchymal stem cells, and platelet rich plasma, for treating surgically induced lesions of the equine superficial digital flexor tendon.. Vet J 2017 Jun;224:76-84.
    doi: 10.1016/j.tvjl.2017.04.005pubmed: 28697880google scholar: lookup
  89. Ricco S, Renzi S, Del Bue M, Conti V, Merli E, Ramoni R, Lucarelli E, Gnudi G, Ferrari M, Grolli S. Allogeneic adipose tissue-derived mesenchymal stem cells in combination with platelet rich plasma are safe and effective in the therapy of superficial digital flexor tendonitis in the horse.. Int J Immunopathol Pharmacol 2013 Jan-Mar;26(1 Suppl):61-8.
    doi: 10.1177/03946320130260S108pubmed: 24046950google scholar: lookup
  90. Dyson SJ. Medical management of superficial digital flexor tendonitis: a comparative study in 219 horses (1992-2000).. Equine Vet J 2004 Jul;36(5):415-9.
    doi: 10.2746/0425164044868422pubmed: 15253082google scholar: lookup
  91. Pacini S, Spinabella S, Trombi L, Fazzi R, Galimberti S, Dini F, Carlucci F, Petrini M. Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses.. Tissue Eng 2007 Dec;13(12):2949-55.
    doi: 10.1089/ten.2007.0108pubmed: 17919069google scholar: lookup
  92. Smith RK. Mesenchymal stem cell therapy for equine tendinopathy.. Disabil Rehabil 2008;30(20-22):1752-8.
    doi: 10.1080/09638280701788241pubmed: 18608378google scholar: lookup
  93. Canapp SO Jr, Canapp DA, Ibrahim V, Carr BJ, Cox C, Barrett JG. The Use of Adipose-Derived Progenitor Cells and Platelet-Rich Plasma Combination for the Treatment of Supraspinatus Tendinopathy in 55 Dogs: A Retrospective Study.. Front Vet Sci 2016;3:61.
    doi: 10.3389/fvets.2016.00061pmc: PMC5016533pubmed: 27668218google scholar: lookup
  94. Canapp SO Jr, Leasure CS, Cox C, Ibrahim V, Carr BJ. Partial Cranial Cruciate Ligament Tears Treated with Stem Cell and Platelet-Rich Plasma Combination Therapy in 36 Dogs: A Retrospective Study.. Front Vet Sci 2016;3:112.
    doi: 10.3389/fvets.2016.00112pmc: PMC5155010pubmed: 28018908google scholar: lookup
  95. Gibson MA, Brown SG, Brown NO. Semitendinosus myopathy and treatment with adipose-derived stem cells in working German shepherd police dogs.. Can Vet J 2017 Mar;58(3):241-246.
    pmc: PMC5302197pubmed: 28246410
  96. McDougall RA, Canapp SO, Canapp DA. Ultrasonographic Findings in 41 Dogs Treated with Bone Marrow Aspirate Concentrate and Platelet-Rich Plasma for a Supraspinatus Tendinopathy: A Retrospective Study.. Front Vet Sci 2018;5:98.
    doi: 10.3389/fvets.2018.00098pmc: PMC5967230pubmed: 29868619google scholar: lookup
  97. Bari E, Perteghella S, Marrubini G, Sorrenti M, Catenacci L, Tripodo G, Mastrogiacomo M, Mandracchia D, Trapani A, Faragò S, Gaetani P, Torre ML. In vitro efficacy of silk sericin microparticles and platelet lysate for intervertebral disk regeneration.. Int J Biol Macromol 2018 Oct 15;118(Pt A):792-799.
    doi: 10.1016/j.ijbiomac.2018.06.135pubmed: 29959012google scholar: lookup
  98. Steffen F, Smolders LA, Roentgen AM, Bertolo A, Stoyanov J. Bone Marrow-Derived Mesenchymal Stem Cells as Autologous Therapy in Dogs with Naturally Occurring Intervertebral Disc Disease: Feasibility, Safety, and Preliminary Results.. Tissue Eng Part C Methods 2017 Nov;23(11):643-651.
    doi: 10.1089/ten.tec.2017.0033pubmed: 28471303google scholar: lookup
  99. Steffen F, Bertolo A, Affentranger R, Ferguson SJ, Stoyanov J. Treatment of Naturally Degenerated Canine Lumbosacral Intervertebral Discs with Autologous Mesenchymal Stromal Cells and Collagen Microcarriers: A Prospective Clinical Study.. Cell Transplant 2019 Feb;28(2):201-211.
    doi: 10.1177/0963689718815459pmc: PMC6362527pubmed: 30488736google scholar: lookup
  100. Sarmento CA, Rodrigues MN, Bocabello RZ, Mess AM, Miglino MA. Pilot study: bone marrow stem cells as a treatment for dogs with chronic spinal cord injury.. Regen Med Res 2014 Dec;2(1):9.
    doi: 10.1186/2050-490X-2-9pmc: PMC4422475pubmed: 25984337google scholar: lookup
  101. Kim Y, Lee SH, Kim WH, Kweon OK. Transplantation of adipose derived mesenchymal stem cells for acute thoracolumbar disc disease with no deep pain perception in dogs.. J Vet Sci 2016 Mar;17(1):123-6.
    doi: 10.4142/jvs.2016.17.1.123pmc: PMC4808638pubmed: 27051350google scholar: lookup
  102. Besalti O, Can P, Akpinar E, Aktas Z, Elcin AE, Elcin YM. Intraspinal Transplantation of Autologous Neurogenically-Induced Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Paraplegic Dogs without Deep Pain Perception Secondary to Intervertebral Disk Disease.. Turk Neurosurg 2015;25(4):625-32.
    doi: 10.5137/1019-5149.JTN.14502-15.2pubmed: 26242341google scholar: lookup
  103. Russell WMS, Burch RL. The Principles of Humane Experimental Technique. Methuen; Wheathampstead, UK: 1959.
  104. Reiner AT, Witwer KW, van Balkom BWM, de Beer J, Brodie C, Corteling RL, Gabrielsson S, Gimona M, Ibrahim AG, de Kleijn D, Lai CP, Lötvall J, Del Portillo HA, Reischl IG, Riazifar M, Salomon C, Tahara H, Toh WS, Wauben MHM, Yang VK, Yang Y, Yeo RWY, Yin H, Giebel B, Rohde E, Lim SK. Concise Review: Developing Best-Practice Models for the Therapeutic Use of Extracellular Vesicles.. Stem Cells Transl Med 2017 Aug;6(8):1730-1739.
    doi: 10.1002/sctm.17-0055pmc: PMC5689784pubmed: 28714557google scholar: lookup
  105. Laible G, Wei J, Wagner S. Improving livestock for agriculture - technological progress from random transgenesis to precision genome editing heralds a new era.. Biotechnol J 2015 Jan;10(1):109-20.
    doi: 10.1002/biot.201400193pubmed: 25515661google scholar: lookup
  106. Van Weeren PR, Tryfonidou MA. Musculoskeletal health from the “One Medicine” perspective—What can we learn from large and.small animal models (with emphasis on articular.cartilage)?. BMC Musculoskelet. Disord. 2015;16:S6.
    doi: 10.1186/1471-2474-16-S1-S6google scholar: lookup
  107. Crivelli B, Chlapanidas T, Perteghella S, Lucarelli E, Pascucci L, Brini AT, Ferrero I, Marazzi M, Pessina A, Torre ML. Mesenchymal stem/stromal cell extracellular vesicles: From active principle to next generation drug delivery system.. J Control Release 2017 Sep 28;262:104-117.
    doi: 10.1016/j.jconrel.2017.07.023pubmed: 28736264google scholar: lookup
  108. Bari E, Ferrarotti I, Torre ML, Corsico AG, Perteghella S. Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through "pharmaceuticalization" for the best formulation.. J Control Release 2019 Sep 10;309:11-24.
    doi: 10.1016/j.jconrel.2019.07.022pubmed: 31326462google scholar: lookup
  109. Bari E, Perteghella S, Catenacci L, Sorlini M, Croce S, Mantelli M, Avanzini MA, Sorrenti M, Torre ML. Freeze-dried and GMP-compliant pharmaceuticals containing exosomes for acellular mesenchymal stromal cell immunomodulant therapy.. Nanomedicine (Lond) 2019 Mar;14(6):753-765.
    doi: 10.2217/nnm-2018-0240pubmed: 30741596google scholar: lookup
  110. Del Fattore A, Luciano R, Pascucci L, Goffredo BM, Giorda E, Scapaticci M, Fierabracci A, Muraca M. Immunoregulatory Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles on T Lymphocytes.. Cell Transplant 2015;24(12):2615-27.
    doi: 10.3727/096368915X687543pubmed: 25695896google scholar: lookup
  111. Capomaccio S, Cappelli K, Bazzucchi C, Coletti M, Gialletti R, Moriconi F, Passamonti F, Pepe M, Petrini S, Mecocci S, Silvestrelli M, Pascucci L. Equine Adipose-Derived Mesenchymal Stromal Cells Release Extracellular Vesicles Enclosing Different Subsets of Small RNAs.. Stem Cells Int 2019;2019:4957806.
    doi: 10.1155/2019/4957806pmc: PMC6442443pubmed: 31011332google scholar: lookup
  112. Malda J, Boere J, van de Lest CH, van Weeren P, Wauben MH. Extracellular vesicles — new tool for joint repair and regeneration.. Nat Rev Rheumatol 2016 Apr;12(4):243-9.
    doi: 10.1038/nrrheum.2015.170pmc: PMC7116208pubmed: 26729461google scholar: lookup
  113. Pascucci L, Coccè V, Bonomi A, Ami D, Ceccarelli P, Ciusani E, Viganò L, Locatelli A, Sisto F, Doglia SM, Parati E, Bernardo ME, Muraca M, Alessandri G, Bondiolotti G, Pessina A. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.. J Control Release 2014 Oct 28;192:262-70.
    doi: 10.1016/j.jconrel.2014.07.042pubmed: 25084218google scholar: lookup
  114. Phinney DG, Pittenger MF. Concise Review: MSC-Derived Exosomes for Cell-Free Therapy.. Stem Cells 2017 Apr;35(4):851-858.
    doi: 10.1002/stem.2575pubmed: 28294454google scholar: lookup
  115. Villatoro AJ, Alcoholado C, Martín-Astorga MC, Fernández V, Cifuentes M, Becerra J. Comparative analysis and characterization of soluble factors and exosomes from cultured adipose tissue and bone marrow mesenchymal stem cells in canine species.. Vet Immunol Immunopathol 2019 Feb;208:6-15.
    doi: 10.1016/j.vetimm.2018.12.003pubmed: 30712794google scholar: lookup
  116. El-Tookhy OS, Shamaa AA, Shehab GG, Abdallah AN, Azzam OM. Histological Evaluation of Experimentally Induced Critical Size Defect Skin Wounds Using Exosomal Solution of Mesenchymal Stem Cells Derived Microvesicles.. Int J Stem Cells 2017 Nov 30;10(2):144-153.
    doi: 10.15283/ijsc17043pmc: PMC5741195pubmed: 29084422google scholar: lookup
  117. Lange-Consiglio A, Rossi D, Tassan S, Perego R, Cremonesi F, Parolini O. Conditioned medium from horse amniotic membrane-derived multipotent progenitor cells: immunomodulatory activity in vitro and first clinical application in tendon and ligament injuries in vivo.. Stem Cells Dev 2013 Nov 15;22(22):3015-24.
    doi: 10.1089/scd.2013.0214pubmed: 23795963google scholar: lookup
  118. Lange-Consiglio A, Romele P, Magatti M, Silini A, Idda A, Martino NA, Cremonesi F, Parolini O. Priming with inflammatory cytokines is not a prerequisite to increase immune-suppressive effects and responsiveness of equine amniotic mesenchymal stromal cells.. Stem Cell Res Ther 2020 Mar 4;11(1):99.
    doi: 10.1186/s13287-020-01611-zpmc: PMC7055152pubmed: 32131892google scholar: lookup
  119. Bari E, Ferrarotti I, Di Silvestre D, Grisoli P, Barzon V, Balderacchi A, Torre ML, Rossi R, Mauri P, Corsico AG, Perteghella S. Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration.. Cells 2019 Aug 23;8(9).
    doi: 10.3390/cells8090965pmc: PMC6770759pubmed: 31450843google scholar: lookup
  120. Li JJ, Hosseini-Beheshti E, Grau GE, Zreiqat H, Little CB. Stem Cell-Derived Extracellular Vesicles for Treating Joint Injury and Osteoarthritis.. Nanomaterials (Basel) 2019 Feb 14;9(2).
    doi: 10.3390/nano9020261pmc: PMC6409698pubmed: 30769853google scholar: lookup
  121. Ranganath SH, Levy O, Inamdar MS, Karp JM. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.. Cell Stem Cell 2012 Mar 2;10(3):244-58.
    doi: 10.1016/j.stem.2012.02.005pmc: PMC3294273pubmed: 22385653google scholar: lookup
  122. Han C, Sun X, Liu L, Jiang H, Shen Y, Xu X, Li J, Zhang G, Huang J, Lin Z, Xiong N, Wang T. Exosomes and Their Therapeutic Potentials of Stem Cells.. Stem Cells Int 2016;2016:7653489.
    doi: 10.1155/2016/7653489pmc: PMC4684885pubmed: 26770213google scholar: lookup
  123. Pawitan JA. Prospect of stem cell conditioned medium in regenerative medicine.. Biomed Res Int 2014;2014:965849.
    doi: 10.1155/2014/965849pmc: PMC4229962pubmed: 25530971google scholar: lookup

Citations

This article has been cited 37 times.
Subscribe to our newsletter
Join 99,727 horse owners like you who receive our email updates on horse health and nutrition.